Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment
Morie A. Gertz
Hematology
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Immunoglobulin Light-chain Amyloidosis
100%
Immunoglobulin Light Chains
61%
Amyloid
42%
pro-brain natriuretic peptide (1-76)
39%
daratumumab
25%
pomalidomide
24%
Smoldering Multiple Myeloma
23%
venetoclax
23%
Bendamustine Hydrochloride
22%
Birefringence
21%
Congo Red
19%
Immunoglobulin Heavy Chains
19%
Natriuretic Peptides
18%
Bortezomib
18%
Troponin T
18%
Biopsy
18%
Troponin I
17%
Nephrotic Syndrome
16%
Delayed Diagnosis
16%
Amyloid Plaques
16%
Peripheral Nervous System Diseases
15%
Stem Cell Transplantation
15%
Plasma Cells
14%
Cyclophosphamide
13%
Dexamethasone
13%
Mass Spectrometry
13%
Therapeutics
12%
Lasers
11%
Heart Failure
10%
Survival
8%
Antibodies
8%
Liver
7%
Serum
6%